Hepatitis A Vaccine (Human Diploid Cell), Inactivated - Healive®
Launched in 2002
lChina's only WHO prequalified hepatitis A vaccine
lAn inactivated hepatitis A vaccine. It is the most widely used hepatitis A vaccine in China, and has the most comprehensive clinical research study results
lEstablishes sustained protection for over 30 years after full-course immunization, based on output of statistical modeling
lExported to a dozen countries in Southeast Asia, Central and South America, the Middle East, and North Africa
lFollowing Healive®, Sinovac launched the first hepatitis A & B combined vaccine in China in 2005 to simultaneously prevent diseases caused by hepatitis A ＆ B viruses.
